Yu Y - Search Results

1

Leukemia, an effective model for chemical biology and target therapy.

Chen GQ, Wang LS, Wu YL, Yu Y. Chen GQ, et al. Among authors: yu y. Acta Pharmacol Sin. 2007 Sep;28(9):1316-24. doi: 10.1111/j.1745-7254.2007.00680.x. Acta Pharmacol Sin. 2007. PMID: 17723165 Review.

2

[Diamide and cyclosporin A enhanced arsenic trioxide-induced apoptosis in NB4 cells].

Yu Y, Jia P, Huang Y, Cai X, Chen G. Yu Y, et al. Zhonghua Xue Ye Xue Za Zhi. 2002 May;23(5):254-7. Zhonghua Xue Ye Xue Za Zhi. 2002. PMID: 12133448 Chinese.

3

[Experimental study of low dose arsenic trioxide in treatment of patients with acute promyelocytic leukemia].

Jia PM, Zhu Q, Yu Y, Chen GQ, Chen SJ, Chen Z, Wang ZY, Tong JH. Jia PM, et al. Among authors: yu y. Ai Zheng. 2002 Apr;21(4):337-40. Ai Zheng. 2002. PMID: 12452006 Chinese.

4

Nanomolar concentration of NSC606985, a camptothecin analog, induces leukemic-cell apoptosis through protein kinase Cdelta-dependent mechanisms.

Song MG, Gao SM, Du KM, Xu M, Yu Y, Zhou YH, Wang Q, Chen Z, Zhu YS, Chen GQ. Song MG, et al. Among authors: yu y. Blood. 2005 May 1;105(9):3714-21. doi: 10.1182/blood-2004-10-4011. Epub 2005 Jan 25. Blood. 2005. PMID: 15671440 Free article.

5

Prediction of pancreatic cancer by serum biomarkers using surface-enhanced laser desorption/ionization-based decision tree classification.

Yu Y, Chen S, Wang LS, Chen WL, Guo WJ, Yan H, Zhang WH, Peng CH, Zhang SD, Li HW, Chen GQ. Yu Y, et al. Oncology. 2005;68(1):79-86. doi: 10.1159/000084824. Epub 2005 Apr 8. Oncology. 2005. PMID: 15864000

6

Metavanadate suppresses desferrioxamine-induced leukemic cell differentiation with reduced hypoxia-inducible factor-1alpha protein.

Xue ZH, Jiang Y, Yu Y, Wang LS, Chen GQ, Zhao Q. Xue ZH, et al. Among authors: yu y. Biochem Biophys Res Commun. 2005 Jul 15;332(4):1140-5. doi: 10.1016/j.bbrc.2005.05.066. Biochem Biophys Res Commun. 2005. PMID: 15935329

7

Hypoxia-simulating agents and selective stimulation of arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells.

Yan H, Peng ZG, Wu YL, Jiang Y, Yu Y, Huang Y, Zhu YS, Zhao Q, Chen GQ. Yan H, et al. Among authors: yu y. Haematologica. 2005 Dec;90(12):1607-16. Haematologica. 2005. PMID: 16330433

8

Therapeutic efficacy of NSC606985, a novel camptothecin analog, in a mouse model of acute promyelocytic leukemia.

Liu W, Zhu YS, Guo M, Yu Y, Chen GQ. Liu W, et al. Among authors: yu y. Leuk Res. 2007 Nov;31(11):1565-74. doi: 10.1016/j.leukres.2007.03.011. Epub 2007 Apr 10. Leuk Res. 2007. PMID: 17428537

9

Subcellular proteome analysis of camptothecin analogue NSC606985-treated acute myeloid leukemic cells.

Yu Y, Wang LS, Shen SM, Xia L, Zhang L, Zhu YS, Chen GQ. Yu Y, et al. J Proteome Res. 2007 Sep;6(9):3808-18. doi: 10.1021/pr0700100. Epub 2007 Jul 27. J Proteome Res. 2007. PMID: 17655343

10

Phosphorylation of beta-actin by protein kinase C-delta in camptothecin analog-induced leukemic cell apoptosis.

Wang S, Zheng Y, Yu Y, Xia L, Chen GQ, Yang YZ, Wang LS. Wang S, et al. Among authors: yu y. Acta Pharmacol Sin. 2008 Jan;29(1):135-42. doi: 10.1111/j.1745-7254.2008.00753.x. Acta Pharmacol Sin. 2008. PMID: 18158875

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41,249 results

Search Page

Filters